Abstract Number: 558 • ACR/ARP Annual Meeting 2019
Frequency and Characteristics of Inflammatory Bowel Disease in Spondyloarthritis with Biological Therapy: Study of 270 Patients from the Same Center
Background/Purpose: Inflammatory bowel disease (IBD) is an extra-articular manifestation that can appear in spondyloarthritis (SpA), as well as uveitis and psoriasis. Its prevalence is 5-10%,…Abstract Number: 231 • ACR/ARHP Annual Meeting 2017
Long Term Survival of Biological Agents in Patients with Axial Spondyloarthritis. the Impact of Sociodemographic Factors in Latin-America
Background/Purpose: The introduction of biological agents improved the prognosis of axial Spon-dyloarthritis (axSpA). The Lund Efficacy Index (LUNDEX) allows evaluation of both survival and efficacy…
ACR Meeting Abstracts